Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
PD-Rx Pharmaceuticals, Inc.

PD-Rx Pharmaceuticals, Inc. Recalls

All product recalls associated with PD-Rx Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Dec 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 25 recalls

Duloxetine Capsules 30mg (PD-Rx) – Nitrosamine Impurity (2024)

CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit

Stay Informed

PD-Rx Pharmaceuticals, Inc. Recalls

Recall Summary

Duloxetine Capsules 30mg (PD-Rx) – Nitrosamine Impurity (2024)

Montelukast Sodium (PD-Rx) – Manufacturing Deviation (2023)

Simvastatin 20mg (PD-Rx) – Manufacturing Deviation (2023)

Glimepiride (PD-Rx) – Manufacturing Deviation (2023)

Simvastatin 10mg (PD-Rx) – Manufacturing Deviation (2023)

Simvastatin 40mg (PD-Rx) – Manufacturing Deviation (2023)

Losartan Potassium 50mg (PD-Rx Pharmaceuticals) – Impurity Levels (2022)

Losartan Potassium 100mg (PD-Rx Pharmaceuticals) – Impurity Levels (2022)

Losartan Potassium Tablets (PD-Rx Pharmaceuticals) – CGMP Impurity Deviation (2022)

Metformin HCL ER (PD-Rx Pharmaceuticals) - NDMA Impurity (2020)

Metformin HCL ER (PD-Rx Pharmaceuticals) - NDMA Impurity (2020)

Nature-Throid (PD-Rx Pharmaceuticals) – Manufacturing Deviation (2020)

Metformin HCL Extended-Release (PD-Rx) – NDMA Impurity (2020)

Metformin HCL Extended-Release (PD-Rx) – NDMA Impurity (2020)

Doxycycline Tablets (PD-Rx) – Failed Dissolution (2020)

Ranitidine Hydrochloride (PD-Rx Pharmaceuticals) – NDMA Contamination (2020)

Losartan Potassium Tablets (PD-Rx) – CGMP Impurity (2019)

Doxycycline Hyclate Tablets (PD-Rx) – Dissolution Failure (2018)

Ibuprofen Tablets (PD-Rx Pharmaceuticals) – Manufacturing Issues (2018)

Phentermine Capsules (PD-Rx Pharmaceuticals) – impurity specifications (2017)